Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1994 Feb;70(820):74–85. doi: 10.1136/pgmj.70.820.74

Infectious diseases.

P D Welsby 1
PMCID: PMC2397644  PMID: 8170896

Full text

PDF
74

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrosch F., André F. E., Delem A., D'Hondt E., Jonas S., Kunz C., Safary A., Wiedermann G. Simultaneous vaccination against hepatitis A and B: results of a controlled study. Vaccine. 1992;10 (Suppl 1):S142–S145. doi: 10.1016/0264-410x(92)90570-a. [DOI] [PubMed] [Google Scholar]
  2. André F. E., D'Hondt E., Delem A., Safary A. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine. 1992;10 (Suppl 1):S160–S168. doi: 10.1016/0264-410x(92)90576-6. [DOI] [PubMed] [Google Scholar]
  3. Archibald C. P., Schechter M. T., Le T. N., Craib K. J., Montaner J. S., O'Shaughnessy M. V. Evidence for a sexually transmitted cofactor for AIDS-related Kaposi's sarcoma in a cohort of homosexual men. Epidemiology. 1992 May;3(3):203–209. doi: 10.1097/00001648-199205000-00004. [DOI] [PubMed] [Google Scholar]
  4. Atkins M., Zambon M., Watkins P. Hepatitis A virus infection. Should susceptible homosexual men be offered immunization. BMJ. 1993 Aug 28;307(6903):562–562. doi: 10.1136/bmj.307.6903.562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bhopal R. S., Diggle P., Rowlingson B. Pinpointing clusters of apparently sporadic cases of Legionnaires' disease. BMJ. 1992 Apr 18;304(6833):1022–1027. doi: 10.1136/bmj.304.6833.1022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Black M. E., Begg N., Behrens R. H. Hepatitis A vaccination. Lancet. 1992 Jul 25;340(8813):244–244. doi: 10.1016/0140-6736(92)90516-6. [DOI] [PubMed] [Google Scholar]
  7. Bradley D. J., Warhurst D. C. Malaria imported into the United Kingdom during 1991. Commun Dis Rep CDR Rev. 1993 Jan 29;3(2):R25–R28. [PubMed] [Google Scholar]
  8. Bradley D. Prophylaxis against malaria for travellers from the United Kingdom. Malaria Reference Laboratory and the Ross Institute. BMJ. 1993 May 8;306(6887):1247–1252. doi: 10.1136/bmj.306.6887.1247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Briggs M., Fox J., Tedder R. S. Age prevalence of antibody to human herpesvirus 6. Lancet. 1988 May 7;1(8593):1058–1059. doi: 10.1016/s0140-6736(88)91883-1. [DOI] [PubMed] [Google Scholar]
  10. Chadee D. D. Bacterial pathogens isolated from guppies (Poecilia reticulata) used to control Aedes aegypti in Trinidad. Trans R Soc Trop Med Hyg. 1992 Nov-Dec;86(6):693–693. doi: 10.1016/0035-9203(92)90194-h. [DOI] [PubMed] [Google Scholar]
  11. Chave J. P., David S., Wauters J. P., Van Melle G., Francioli P. Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. AIDS. 1991 Aug;5(8):927–932. doi: 10.1097/00002030-199108000-00002. [DOI] [PubMed] [Google Scholar]
  12. Cooke B. Immunisation, not vaccination. BMJ. 1992 May 16;304(6837):1313–1313. doi: 10.1136/bmj.304.6837.1313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dodd R. Y. The risk of transfusion-transmitted infection. N Engl J Med. 1992 Aug 6;327(6):419–421. doi: 10.1056/NEJM199208063270610. [DOI] [PubMed] [Google Scholar]
  14. Donahue J. G., Muñoz A., Ness P. M., Brown D. E., Jr, Yawn D. H., McAllister H. A., Jr, Reitz B. A., Nelson K. E. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992 Aug 6;327(6):369–373. doi: 10.1056/NEJM199208063270601. [DOI] [PubMed] [Google Scholar]
  15. Dooley S. W., Jarvis W. R., Martone W. J., Snider D. E., Jr Multidrug-resistant tuberculosis. Ann Intern Med. 1992 Aug 1;117(3):257–259. doi: 10.7326/0003-4819-117-3-257. [DOI] [PubMed] [Google Scholar]
  16. Durand M. L., Calderwood S. B., Weber D. J., Miller S. I., Southwick F. S., Caviness V. S., Jr, Swartz M. N. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med. 1993 Jan 7;328(1):21–28. doi: 10.1056/NEJM199301073280104. [DOI] [PubMed] [Google Scholar]
  17. Evans B. G., Catchpole M. A., Heptonstall J., Mortimer J. Y., McCarrigle C. A., Nicoll A. G., Waight P., Gill O. N., Swan A. V. Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales. BMJ. 1993 Feb 13;306(6875):426–428. doi: 10.1136/bmj.306.6875.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fidler H. M., Rook G. A., Johnson N. M., McFadden J. Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. BMJ. 1993 Feb 27;306(6877):546–549. doi: 10.1136/bmj.306.6877.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Fischl M. A., Daikos G. L., Uttamchandani R. B., Poblete R. B., Moreno J. N., Reyes R. R., Boota A. M., Thompson L. M., Cleary T. J., Oldham S. A. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med. 1992 Aug 1;117(3):184–190. doi: 10.7326/0003-4819-117-3-184. [DOI] [PubMed] [Google Scholar]
  20. Frieden T. R., Sterling T., Pablos-Mendez A., Kilburn J. O., Cauthen G. M., Dooley S. W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med. 1993 Feb 25;328(8):521–526. doi: 10.1056/NEJM199302253280801. [DOI] [PubMed] [Google Scholar]
  21. Gazzard B. G., Wastell C. HIV and surgeons. BMJ. 1990 Nov 3;301(6759):1003–1004. doi: 10.1136/bmj.301.6759.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Gimson A. E., White Y. S., Eddleston A. L., Williams R. Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B. Gut. 1983 Dec;24(12):1194–1198. doi: 10.1136/gut.24.12.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Glasziou P. P., Mackerras D. E. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ. 1993 Feb 6;306(6874):366–370. doi: 10.1136/bmj.306.6874.366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Goble M., Iseman M. D., Madsen L. A., Waite D., Ackerson L., Horsburgh C. R., Jr Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med. 1993 Feb 25;328(8):527–532. doi: 10.1056/NEJM199302253280802. [DOI] [PubMed] [Google Scholar]
  25. Grayston J. T., Campbell L. A., Kuo C. C., Mordhorst C. H., Saikku P., Thom D. H., Wang S. P. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990 Apr;161(4):618–625. doi: 10.1093/infdis/161.4.618. [DOI] [PubMed] [Google Scholar]
  26. Greenwood A. M., Armstrong J. R., Byass P., Snow R. W., Greenwood B. M. Malaria chemoprophylaxis, birth weight and child survival. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):483–485. doi: 10.1016/0035-9203(92)90078-q. [DOI] [PubMed] [Google Scholar]
  27. Grey M. R. Syphilis and AIDS in Belle Glade, Florida, 1942 and 1992. Ann Intern Med. 1992 Feb 15;116(4):329–334. doi: 10.7326/0003-4819-116-4-329. [DOI] [PubMed] [Google Scholar]
  28. Harrison P. J., Roberts G. W. How now mad cow? BMJ. 1992 Apr 11;304(6832):929–930. doi: 10.1136/bmj.304.6832.929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hashiguchi K., Ogawa H., Kazuyama Y. Seroprevalence of Chlamydia pneumoniae infections in otolaryngeal diseases. J Laryngol Otol. 1992 Mar;106(3):208–210. doi: 10.1017/s0022215100119097. [DOI] [PubMed] [Google Scholar]
  30. Hunter G., Bagshawe A. F., Baboo K. S., Luke R., Prociv P. Intestinal parasites in Zambian patients with AIDS. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):543–545. doi: 10.1016/0035-9203(92)90102-i. [DOI] [PubMed] [Google Scholar]
  31. Khattak M. N., Matthews R. C., Burnie J. P. Is Bordetella pertussis clonal? BMJ. 1992 Mar 28;304(6830):813–815. doi: 10.1136/bmj.304.6830.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Leentvaar-Kuijpers A., Coutinho R. A., Brulein V., Safary A. Simultaneous passive and active immunization against hepatitis A. Vaccine. 1992;10 (Suppl 1):S138–S141. doi: 10.1016/0264-410x(92)90569-6. [DOI] [PubMed] [Google Scholar]
  33. Lewis S. J., Davidson R. N., Ross E. J., Hall A. P. Severity of imported falciparum malaria: effect of taking antimalarial prophylaxis. BMJ. 1992 Sep 26;305(6856):741–743. doi: 10.1136/bmj.305.6856.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Marcus R. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus. N Engl J Med. 1988 Oct 27;319(17):1118–1123. doi: 10.1056/NEJM198810273191703. [DOI] [PubMed] [Google Scholar]
  35. Miller E., Waight P. A., Vurdien J. E., Jones G., Tookey P. A., Peckham C. S. Rubella surveillance to December 1992: second joint report from the PHLS and National Congenital Rubella Surveillance Programme. Commun Dis Rep CDR Rev. 1993 Feb 26;3(3):R35–R40. [PubMed] [Google Scholar]
  36. O'Grady J. Management of acute and fulminant hepatitis A. Vaccine. 1992;10 (Suppl 1):S21–S23. doi: 10.1016/0264-410x(92)90535-r. [DOI] [PubMed] [Google Scholar]
  37. Pablos-Méndez A., Netto E. M., Defendini R. Infectious prions or cytotoxic metabolites? Lancet. 1993 Jan 16;341(8838):159–161. doi: 10.1016/0140-6736(93)90018-c. [DOI] [PubMed] [Google Scholar]
  38. Pearson M. L., Jereb J. A., Frieden T. R., Crawford J. T., Davis B. J., Dooley S. W., Jarvis W. R. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. A risk to patients and health care workers. Ann Intern Med. 1992 Aug 1;117(3):191–196. doi: 10.7326/0003-4819-117-3-191. [DOI] [PubMed] [Google Scholar]
  39. Pruksananonda P., Hall C. B., Insel R. A., McIntyre K., Pellett P. E., Long C. E., Schnabel K. C., Pincus P. H., Stamey F. R., Dambaugh T. R. Primary human herpesvirus 6 infection in young children. N Engl J Med. 1992 May 28;326(22):1445–1450. doi: 10.1056/NEJM199205283262201. [DOI] [PubMed] [Google Scholar]
  40. Saikku P., Leinonen M., Tenkanen L., Linnanmäki E., Ekman M. R., Manninen V., Mänttäri M., Frick M. H., Huttunen J. K. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992 Feb 15;116(4):273–278. doi: 10.7326/0003-4819-116-4-273. [DOI] [PubMed] [Google Scholar]
  41. Salahuddin S. Z., Ablashi D. V., Markham P. D., Josephs S. F., Sturzenegger S., Kaplan M., Halligan G., Biberfeld P., Wong-Staal F., Kramarsky B. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 1986 Oct 31;234(4776):596–601. doi: 10.1126/science.2876520. [DOI] [PubMed] [Google Scholar]
  42. Scadding J. G. Mycobacteria and sarcoidosis. Clinical studies support link. BMJ. 1993 May 8;306(6887):1269–1271. doi: 10.1136/bmj.306.6887.1269-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Shanson D. C. Current surgical controversies over HIV infection. J Hosp Infect. 1991 Feb;17(2):77–81. doi: 10.1016/0195-6701(91)90171-4. [DOI] [PubMed] [Google Scholar]
  44. Shapiro E. D., Gerber M. A., Holabird N. B., Berg A. T., Feder H. M., Jr, Bell G. L., Rys P. N., Persing D. H. A controlled trial of antimicrobial prophylaxis for Lyme disease after deer-tick bites. N Engl J Med. 1992 Dec 17;327(25):1769–1773. doi: 10.1056/NEJM199212173272501. [DOI] [PubMed] [Google Scholar]
  45. Steffen R., Fuchs E., Schildknecht J., Naef U., Funk M., Schlagenhauf P., Phillips-Howard P., Nevill C., Stürchler D. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa. Lancet. 1993 May 22;341(8856):1299–1303. doi: 10.1016/0140-6736(93)90814-w. [DOI] [PubMed] [Google Scholar]
  46. Steffen R. Risk of hepatitis A in travellers. Vaccine. 1992;10 (Suppl 1):S69–S72. doi: 10.1016/0264-410x(92)90548-x. [DOI] [PubMed] [Google Scholar]
  47. Taveira da Silva A. M., Kaulbach H. C., Chuidian F. S., Lambert D. R., Suffredini A. F., Danner R. L. Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin. N Engl J Med. 1993 May 20;328(20):1457–1460. doi: 10.1056/NEJM199305203282005. [DOI] [PubMed] [Google Scholar]
  48. Tilzey A. J., Palmer S. J., Barrow S., Perry K. R., Tyrrell H., Safary A., Banatvala J. E. Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. BMJ. 1992 May 16;304(6837):1272–1276. doi: 10.1136/bmj.304.6837.1272. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tompkins L. S. The use of molecular methods in infectious diseases. N Engl J Med. 1992 Oct 29;327(18):1290–1297. doi: 10.1056/NEJM199210293271808. [DOI] [PubMed] [Google Scholar]
  50. Voss S. How much do doctors know about the notification of infectious diseases? BMJ. 1992 Mar 21;304(6829):755–755. doi: 10.1136/bmj.304.6829.755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Warren H. S., Danner R. L., Munford R. S. Anti-endotoxin monoclonal antibodies. N Engl J Med. 1992 Apr 23;326(17):1153–1157. doi: 10.1056/NEJM199204233261711. [DOI] [PubMed] [Google Scholar]
  52. Watt G., Shanks G. D., Phintuyothin P. Prognostic significance of rises in parasitaemia during treatment of falciparum malaria. Trans R Soc Trop Med Hyg. 1992 Jul-Aug;86(4):359–360. doi: 10.1016/0035-9203(92)90217-z. [DOI] [PubMed] [Google Scholar]
  53. Weiss E., Strauss B. S. The life and career of Howard Taylor Ricketts. Rev Infect Dis. 1991 Nov-Dec;13(6):1241–1242. doi: 10.1093/clinids/13.6.1241. [DOI] [PubMed] [Google Scholar]
  54. Welsby P. D. Should clinicians accept management responsibilities? Postgrad Med J. 1992 Aug;68(802):671–672. doi: 10.1136/pgmj.68.802.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Wenzel R. P. Anti-endotoxin monoclonal antibodies--a second look. N Engl J Med. 1992 Apr 23;326(17):1151–1153. doi: 10.1056/NEJM199204233261710. [DOI] [PubMed] [Google Scholar]
  56. Wiedermann G., Ambrosch F., André F. E., D'Hondt E., Delem A., Safary A. Persistence of vaccine-induced antibody to hepatitis A virus. Vaccine. 1992;10 (Suppl 1):S129–S131. doi: 10.1016/0264-410x(92)90566-3. [DOI] [PubMed] [Google Scholar]
  57. Wilcox M. H., Spencer R. C. Quinolones and Salmonella gastroenteritis. J Antimicrob Chemother. 1992 Aug;30(2):221–228. doi: 10.1093/jac/30.2.221. [DOI] [PubMed] [Google Scholar]
  58. Wilson S. M., Nava E., Morales A., Godfrey-Faussett P., Gillespie S., Andersson N. Simplification of the polymerase chain reaction for detection of Mycobacterium tuberculosis in the tropics. Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):177–180. doi: 10.1016/0035-9203(93)90478-9. [DOI] [PubMed] [Google Scholar]
  59. Wiström J., Jertborn M., Ekwall E., Norlin K., Söderquist B., Strömberg A., Lundholm R., Hogevik H., Lagergren L., Englund G. Empiric treatment of acute diarrheal disease with norfloxacin. A randomized, placebo-controlled study. Swedish Study Group. Ann Intern Med. 1992 Aug 1;117(3):202–208. doi: 10.7326/0003-4819-117-3-202. [DOI] [PubMed] [Google Scholar]
  60. Wyatt H. V., Mahadevan S., Srinivasan S. Unnecessary injections and paralytic poliomyelitis in India. Trans R Soc Trop Med Hyg. 1992 Sep-Oct;86(5):546–549. doi: 10.1016/0035-9203(92)90104-k. [DOI] [PubMed] [Google Scholar]
  61. Yamanishi K., Okuno T., Shiraki K., Takahashi M., Kondo T., Asano Y., Kurata T. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet. 1988 May 14;1(8594):1065–1067. doi: 10.1016/s0140-6736(88)91893-4. [DOI] [PubMed] [Google Scholar]
  62. de Moraes J. C., Perkins B. A., Camargo M. C., Hidalgo N. T., Barbosa H. A., Sacchi C. T., Landgraf I. M., Gattas V. L., Vasconcelos H. de G., Gral I. M. Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet. 1992 Oct 31;340(8827):1074–1078. doi: 10.1016/0140-6736(92)93086-3. [DOI] [PubMed] [Google Scholar]
  63. de Rossell R. A., de Duran R. J., Rossell O., Rodríguez A. M. Is leishmaniasis ever cured? Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):251–253. doi: 10.1016/0035-9203(92)90297-p. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES